Ads
related to: crispr therapeutics news
Search results
Is CRISPR Therapeutics a Buy in the New Bull Market?
Motley Fool via Yahoo Finance· 4 months agoCRISPR Therapeutics (NASDAQ: CRSP) soared 54% last year as growth stocks rallied and the company itself moved toward an important milestone: the approval...
Is CRISPR Therapeutics Stock a Buy Now?
Motley Fool· 1 year agoGene-editing specialist CRISPR Therapeutics (NASDAQ: CRSP) has significantly lagged the market over the past year, but there are reasons to be optimistic...
Can CRISPR Therapeutics Stock Double in 5 Years? Here's What It Would Take.
Motley Fool· 6 months agoCRISPR Therapeutics (NASDAQ: CRSP) has reached a very exciting point in its story. The biotech...
If You Invested $5,000 in CRISPR Therapeutics in January, This Is How Much You Would Have Today
Motley Fool· 5 months agoCRISPR Therapeutics' (NASDAQ: CRSP) stock has soared this year -- and for good reason. The biotech...
One Month Ahead of its Most Crucial Moment Ever, Should You Buy CRISPR Therapeutics?
Motley Fool· 6 months agoCRISPR Therapeutics (NASDAQ: CRSP) has reached a very important chapter in its growth story. The...
Here's a New Million-Dollar Reason to Buy CRISPR Therapeutics
Motley Fool· 1 year agoCRISPR Therapeutics (NASDAQ: CRSP) is heading for an important moment: the potential approval of its...
Better Growth Stock: CRISPR Therapeutics vs. Teladoc Health
Motley Fool· 12 months agoCRISPR Therapeutics (NASDAQ: CRSP) and Teladoc Health (NYSE: TDOC) both score a win when it comes to...
Here's the 1 Key Reason You Might Want to Buy CRISPR Therapeutics Stock on the Dip
Motley Fool via Yahoo Finance· 5 months agoIt's now a new ballgame for CRISPR Therapeutics (NASDAQ: CRSP). The company, along with its big...
What Does It Mean for Investors if CRISPR Therapeutics Gets Bought Out in 2024?
Motley Fool via Yahoo Finance· 4 months agoCRISPR Therapeutics (NASDAQ: CRSP) has put itself on the map of the healthcare industry as a serious...
6 Words That Explain Why CRISPR Stock Isn't Soaring Despite the Recent FDA Approval for Its...
Motley Fool via Yahoo Finance· 5 months agoDecember has been a big month for CRISPR Therapeutics (NASDAQ: CRSP). On Dec. 8, the Food and Drug...
